Logotype for Granules India Limited

Granules India (532482) investor relations material

Granules India Q1 25/26 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Granules India Limited
Q1 25/26 earnings summary12 Aug, 2025

Executive summary

  • Q1 FY26 revenue grew 3% year-over-year to INR 12,101 million, with gross margin improvement aided by Senn Chemicals AG consolidation and continued investments in R&D and strategic expansion into peptides and CDMO segments.

  • Remediation at the Gagilapur facility is nearing completion, with FDA reinspection expected by December, aiming to resolve delivery constraints and support growth; USFDA warning letter and voluntary pause impacted revenue and costs.

  • Senn Chemicals AG contributed INR 291 million in Q1 FY26, marking entry into high-growth peptide CDMO space and segment diversification.

  • PAT declined 16% year-over-year to INR 1,126 million due to exceptional expenses from litigation settlements and acquisition-related costs.

  • Sustainability initiatives recognized with CDP Supplier Engagement A List, EcoVadis Gold Medal, and improved ESG scores.

Financial highlights

  • Q1 FY26 revenue: INR 12,101 million, up 3% year-over-year and 1% sequentially.

  • Gross margin: 64.9%, up 593 bps year-over-year, aided by Senn Chemicals AG consolidation.

  • EBITDA: INR 2,467 million (20.4% of sales), down 5% year-over-year due to higher professional, remediation, and manpower expenses.

  • PAT: INR 1,126 million, margin at 9.3%, down 16% year-over-year due to exceptional items.

  • Cash flow from operations: INR 2,806 million; CapEx: INR 1,037–1,137 million.

Outlook and guidance

  • Significant growth expected from Q4 FY26 and into FY27 as remediation concludes and new product approvals ramp up.

  • Peptide CDMO business expected to match group return metrics within 12–18 months.

  • Europe revenue contribution projected to rise to 15–20% of total revenue, driven by capacity expansion and new launches.

  • New R&D facility for peptide development being added at IIT Hyderabad, with continued focus on innovation and sustainability.

  • Ongoing remediation at Gagilapur expected to continue affecting results.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Granules India earnings date

Logotype for Granules India Limited
Q2 25/265 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Granules India earnings date

Logotype for Granules India Limited
Q2 25/265 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Granules India Limited is a pharmaceutical company engaged in the manufacturing and distribution of active pharmaceutical ingredients (APIs), pharmaceutical formulations intermediates (PFIs), and finished dosage forms (FDFs). The company serves global pharmaceutical markets, supplying essential medicines across therapeutic categories such as pain management, cardiovascular, and anti-infectives. The company operates manufacturing facilities in India and internationally. It is headquartered in Hyderabad, India, and its shares are listed on the BSE.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage